Authors: Caroline Barkholt Kamp; Johanne Juul Petersen; Pascal Faltermeier; Sophie Juul; Faiza Siddiqui; Marija Barbateskovic; Andreas Torp Kristensen; Joanna Moncrieff; Mark Abie Horowitz; Michael Pascal Hengartner; Irving Kirsch; Christian Gluud; Janus Christian Jakobsen · Research

How Safe and Effective Are Tricyclic Antidepressants for Depression Treatment?

A comprehensive review examining both benefits and risks of tricyclic antidepressants in treating major depression

Source: Kamp, C. B., Petersen, J. J., Faltermeier, P., Juul, S., Siddiqui, F., Barbateskovic, M., ... & Jakobsen, J. C. (2024). Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis. BMJ Mental Health, 27, 1-14.

What you need to know

  • Tricyclic antidepressants may help reduce depression symptoms in the short-term, but evidence quality is low
  • These medications significantly increase the risk of serious side effects
  • Long-term effects and impacts on quality of life remain unknown due to lack of research

The Depression Treatment Dilemma

Depression affects over 264 million people worldwide and can have devastating consequences, including increased risk of suicide. While antidepressant medications are commonly prescribed, patients and doctors often struggle with weighing their potential benefits against risks. Tricyclic antidepressants are one of the older classes of antidepressants still widely used today, particularly when newer medications aren’t effective. But how well do they actually work, and what are the tradeoffs?

What the Research Shows

This comprehensive review analyzed 103 clinical trials including over 10,500 participants with major depression. The researchers found that tricyclic antidepressants did reduce depression symptoms more than placebo pills in the short term (up to 12 weeks). However, this improvement averaged only about 3-4 points on a standard depression rating scale - just barely reaching what’s considered a meaningful clinical difference.

Safety Concerns

The review uncovered significant safety issues. People taking tricyclic antidepressants were nearly three times more likely to experience serious adverse events compared to those taking placebo. The most concerning side effects included:

  • Dangerously low blood pressure
  • Urinary retention
  • Vision problems
  • Sexual dysfunction
  • Altered taste

Additionally, over 63% of people taking tricyclics reported less severe but still troubling side effects like dry mouth, drowsiness, constipation, dizziness and excessive sweating.

Major Knowledge Gaps

Perhaps most concerning is what we don’t know. None of the studies followed patients longer than 12 weeks, so the long-term effects remain a mystery. This is particularly problematic since many people take these medications for years. Only two small studies examined impacts on quality of life, and there wasn’t enough data to determine effects on suicide risk.

What This Means for You

If you’re considering tricyclic antidepressants, have an informed discussion with your healthcare provider about:

  • Your individual risk factors for side effects
  • Alternative treatment options
  • A clear plan for monitoring benefits and adverse effects
  • How long you might need to take the medication
  • A strategy for safely stopping if needed

Remember that responses to antidepressants vary greatly between individuals. What works well for one person may not work for another.

Conclusions

  • While tricyclic antidepressants may provide modest short-term benefits for depression, they come with significant risks
  • More research is urgently needed on long-term effects and impacts on quality of life
  • Treatment decisions should be highly individualized, weighing potential benefits against known risks
Back to Blog

Related Articles

View All Articles »